Tesfai, Yordanos <br/><br/>
Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.  [electronic resource] 

 -  Leukemia research  Mar 2012 
 - 299-306 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-5835 
<br/><br/><label>Standard No.: </label>10.1016/j.leukres.2011.08.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, CD34--metabolism<br/>Antimetabolites, Antineoplastic--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Antineoplastic Agents, Hormonal--pharmacology<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Asparaginase--pharmacology<br/>Biomarkers, Tumor--genetics<br/>Bone Marrow Cells--drug effects<br/>Case-Control Studies<br/>Cell Communication--drug effects<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>Child<br/>Cohort Studies<br/>Cytarabine--pharmacology<br/>Dexamethasone--pharmacology<br/>Gene Expression Profiling<br/>Humans<br/>Neoplasm Staging<br/>Oligonucleotide Array Sequence Analysis<br/>Precursor B-Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Precursor T-Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Principal Component Analysis<br/>Prognosis<br/>RNA, Messenger--genetics<br/>Real-Time Polymerase Chain Reaction<br/>Stromal Cells--drug effects<br/>Vincristine--pharmacology